Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population

Eur J Immunogenet. 1998 Aug;25(4):317-20. doi: 10.1046/j.1365-2370.1998.00110.x.

Abstract

Genetic susceptibility to systemic lupus erythematosus (SLE) may vary amongst different populations. In UK patients, genes encoded in the HLA class II (DQA*0501/DRB1*0301) and class III [C4A*Q0 and tumour necrosis factor (TNF) polymorphisms] subregions appear to contribute to disease susceptibility. We have examined HLA-DRB1, C4 and TNF microsatellites in 50 Spanish SLE patients and 48 matched controls. HLA-DRB1*0301 was increased in patients but did not achieve statistical significance (41% vs. 25.5%). C4A*Q0 was not increased in patients, but C4B*Q0 allele frequency was significantly increased compared with the controls (29% vs. 6%; OR: 6.0). TNF c2 microsatellite allele frequency was also increased in SLE patients. The C4B null allele (C4B*Q0) appears to play an important role in SLE susceptibility in the Spanish population.

MeSH terms

  • Alleles
  • Case-Control Studies
  • Complement C4b / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • HLA-DR Antigens / genetics
  • HLA-DRB1 Chains
  • Humans
  • Lupus Erythematosus, Systemic / genetics*
  • Lupus Erythematosus, Systemic / immunology
  • Male
  • Microsatellite Repeats
  • Polymorphism, Genetic
  • Risk Factors
  • Spain
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*03:01 antigen
  • Tumor Necrosis Factor-alpha
  • Complement C4b